Our Services
Medical Information
Helpful Resources
Published on: 10/22/2026
Hormone replacement therapy is not always stopped before surgery, and the decision depends on several factors, including the type of procedure, your risk of blood clots, the hormone formulation, and the route of delivery. Many surgeons ask patients to pause estrogen-containing HRT roughly four weeks before major or prolonged operations, especially orthopedic, pelvic, or cancer surgery, while minor procedures with low clot risk often require no interruption at all. Transdermal patches and gels may carry a lower thrombotic risk than oral tablets, so some clinicians continue them through surgery alongside preventive measures such as compression stockings and blood thinners. Stopping suddenly can trigger a return of hot flashes, insomnia, and mood changes, so timing and restart plans matter as much as the pause itself. There are important details and exceptions to weigh before changing anything, so see below to understand more.
If you are facing surgery and unsure how your hormone therapy fits in, it helps to get clarity on your own symptoms and risk picture before your pre-op appointment. A free, instant, online symptom check can help you organize what you are experiencing, flag concerns worth raising with your surgeon or prescriber, and point you toward sensible next steps. Walking into that conversation prepared means fewer surprises, better questions, and a plan built around your situation rather than a general rule.
Last reviewed for medical accuracy: 10/22/2026
Undergoing surgery involves careful planning of all medications, including hormone replacement therapy (HRT). Whether you’re taking estrogen, testosterone, thyroid hormone or other replacements, coordinating with your healthcare team helps reduce risks and supports a smoother recovery. Below is a practical overview of when and why certain hormones may need to be paused or adjusted before surgery.
Clotting Risks
• Estrogen and, to a lesser extent, testosterone can raise the chance of blood clots (venous thromboembolism).
• Surgery itself increases clotting risk due to immobility and tissue injury.
Metabolic Demands
• Thyroid and adrenal hormones influence your body’s stress response.
• Stopping or altering these could lead to under- or over-reaction to surgical stress.
Recovery and Wound Healing
• Certain hormones affect how tissues repair.
• Optimizing levels helps wounds heal more effectively.
Compile Your Medication List
• Include all hormones, over-the-counter treatments, herbs and supplements.
• Note dosages, routes (oral, patch, injection) and last administration date.
Assess Your Personal Risk
• Prior clot history, obesity, smoking or family history of clots ups the stakes.
• Major surgery (orthopedic, abdominal) carries higher risk than minor outpatient procedures.
Coordinate with Specialists
• Surgeon, anesthesiologist and your hormone-prescribing doctor should align on timing.
• Endocrinologists often guide tapering and restarting schedules.
Plan Thromboprophylaxis
• Mechanical (compression stockings) and/or chemical (low-molecular-weight heparin) strategies may be used.
• Understanding when you can safely resume hormone therapy helps set the clot-prevention plan.
Monitor Symptoms
• Watch for unusual leg pain or swelling, chest discomfort or shortness of breath—signs of clotting.
• Track hormonal symptoms (e.g., hot flashes if estrogen is paused).
Q: “Can I skip one estrogen pill the day of surgery?”
A: A single dose probably won’t make a big difference—but check with your surgeon first. Often, the goal is to miss a series of doses to lower clot risk meaningfully.
Q: “What if I’m worried about severe menopausal symptoms?”
A: Ask your provider about non-hormonal alternatives for symptom relief (e.g., SSRIs, lifestyle strategies) during the HRT pause.
Q: “My surgery was postponed—do I restart HRT?”
A: Yes, unless you’ve already reached the recommended window without HRT. Restart at the agreed time and dose.
• Hormone replacement therapy before surgery must strike the right balance between reducing surgical risks and managing the symptoms or conditions HRT treats.
• Every person’s health profile and surgery type differ, so there’s no one-size-fits-all.
• Open, clear communication with your medical team ensures you get the safest, most effective plan.
If you’re experiencing any new or troubling symptoms—whether related to surgery prep, hormone side effects or otherwise—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a quick way to gather insights before your medical appointment.
Important: This information is intended to guide general understanding. Always speak to a doctor about changes to hormone replacement therapy before surgery, especially if you experience serious or life-threatening issues such as sudden shortness of breath, chest pain or signs of stroke. Your healthcare team knows your unique history best and will tailor instructions to keep you safe and supported.
(References)
* Hofseth LJ, Raafat AM, Osuch JR, Pathak DR, Slomski CA, Haslam SZ. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab. 1999 Dec;84(12):4559-65. doi: 10.1210/jcem.84.12.6194. PMID: 10599719.
* Thompson S. Support service. Nurs Stand. 2001 Jul 11-17;15(43):27. doi: 10.7748/ns.15.43.27.s44. PMID: 12211871.
* Haskell SG. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy. J Womens Health (Larchmt). 2004 May;13(4):438-42. doi: 10.1089/154099904323087132. PMID: 15186661.
* Boisserie-Lacroix M, Lebiez-Michel N, Cavagni P, Bentolila J, Laumonier H, Bouzgarrou M, Trillaud H. [Hormones and mammographic breast density]. J Radiol. 2008 Sep;89(9 Pt 2):1196-203. doi: 10.1016/s0221-0363(08)73930-1. PMID: 18772804.
* Girard NJ. Inadvertent castration. AORN J. 2010 Mar;91(3):422, 325. doi: 10.1016/j.aorn.2009.12.022. PMID: 20193808.
* Weissmann-Brenner A, Brenner B, Sulkes J, Kaplan B. Women gynecologists' attitude toward their own health. Med Sci Monit. 2010 Apr;16(4):PH35-39. PMID: 20357729.
* Kyvernitakis I, Kostev K, Hars O, Albert US, Kalder M, Hadji P. Persistency with estrogen replacement therapy among hysterectomized women after the Women's Health Initiative study. Climacteric. 2015;18(6):826-34. doi: 10.3109/13697137.2015.1081164. Epub 2015 Oct 30. PMID: 26517429.
* Chen SS, Zaborek NA, Doubleday AR, Schaefer SC, Long KL, Pitt SC, Sippel RS, Schneider DF. Optimizing Levothyroxine Dose Adjustment After Thyroidectomy With a Decision Tree. J Surg Res. 2019 Dec;244:102-106. doi: 10.1016/j.jss.2019.06.025. Epub 2019 Jul 4. PMID: 31279993; PMCID: PMC7041547.
* Bourdel N, Huchon C, Abdel Wahab C, Azaïs H, Bendifallah S, Bolze PA, Brun JL, Canlorbe G, Chauvet P, Chereau E, Courbiere B, De La Motte Rouge T, Devouassoux-Shisheboran M, Eymerit-Morin C, Fauvet R, Gauroy E, Gauthier T, Grynberg M, Koskas M, Larouzee E, Lecointre L, Levêque J, Margueritte F, D'argent Mathieu E, Nyangoh-Timoh K, Ouldamer L, Raad J, Raimond E, Ramanah R, Rolland L, Rousset P, Rousset-Jablonski C, Thomassin-Naggara I, Uzan C, Zilliox M, Daraï E. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation. J Gynecol Obstet Hum Reprod. 2021 Jan;50(1):101966. doi: 10.1016/j.jogoh.2020.101966. Epub 2020 Nov 2. PMID: 33144266.
* Jörg I, Chronas D. Hormonal management after risk-reducing surgery in BRCA-mutated triple-negative breast cancer survivors. J Cancer Res Clin Oncol. 2026 Mar 7;152(3). doi: 10.1007/s00432-026-06425-9. Epub 2026 Mar 7. PMID: 41793502; PMCID: PMC12967752.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.